3.4.21.118: kallikrein 8
This is an abbreviated version!
For detailed information about kallikrein 8, go to the full flat file.
Word Map on EC 3.4.21.118
-
3.4.21.118
-
kallikreins
-
klk8
-
melanopsin
-
desquamation
-
photopigment
-
iprgcs
-
non-visual
-
peropsin
-
medicine
-
biotechnology
-
molecular biology
-
pharmacology
-
analysis
- 3.4.21.118
- kallikreins
- klk8
- melanopsin
-
desquamation
-
photopigment
-
iprgcs
-
non-visual
-
peropsin
- medicine
- biotechnology
- molecular biology
- pharmacology
- analysis
Reaction
cleavage of amide substrates following the basic amino acids Arg or Lys at the P1 position, with a preference for Arg over Lys =
Synonyms
Alzheimers associated protease, brain serine protease 1, GK-8, hK8, kallikrein 8, kallikrein 8 protease, kallikrein-8, kallikrein-related peptidase, kallikrein-related peptidase 8, kallikrein-related peptidase-8, KLK8, KRP/hK8, mK8, neuropsin, NP, ovasin, P1 kallikrein, PRSS19, RGK-8, S01.244, TADG-14, TADG14, tissue kallikrein, type I neuropsin, type II neuropsin
ECTree
Advanced search results
Expression
Expression on EC 3.4.21.118 - kallikrein 8
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
expression of Klk8 in the imiquimod-treated skin is significantly higher than that in untreated skin
KLK8 expression is increased 4fold in cell lines with overexpressing urinary type plasminogen activator and receptor versus cell lines with silencing of urinary type plasminogen activator and receptor
KLK8 protein expression increases during terminal keratinocyte differentiation
-
neuropsin is upregulated in the epidermis of sodium lauryl sulfate-treated mouse skin
-
oligodendrocytes only express Klk8 mRNA after injury to the central nervous system
-
KLK8 expression is increased 4fold in cell lines with overexpressing urinary type plasminogen activator and receptor versus cell lines with silencing of urinary type plasminogen activator and receptor
-
KLK8 expression is increased 4fold in cell lines with overexpressing urinary type plasminogen activator and receptor versus cell lines with silencing of urinary type plasminogen activator and receptor
-